IL0011417206 - Common Stock
SOL-GEL TECHNOLOGIES LTD
NASDAQ:SLGL (12/24/2024, 7:38:04 PM)
After market: 0.8501 -0.13 (-13.24%)0.9798
-0.67 (-40.62%)
Sol-Gel Technologies Ltd. operates as a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. The firm is focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The Company’s offers a range of products twins, sirs-t, and vered. The firm is designed its proprietary, silica-based microencapsulation technology platform to enhance the tolerability and stability of topical drugs while maintaining their efficacy. Topical drugs often struggle to balance achieving both high efficacy and high tolerability. Its technology platform entraps active ingredients in an inert, inorganic silica shell, which creates an unnoticeable barrier between the active ingredient and the skin.
SOL-GEL TECHNOLOGIES LTD
Golda Meir 7
Ness Ziona 7403648
P: 97289313433
CEO: Alon Seri-Levy
Employees: 36
Website: http://www.sol-gel.com
Top movers analysis one hour before the close of the markets on 2024-12-24: top gainers and losers in today's session.
Stay up-to-date with the latest market trends in the middle of the day on Tuesday. Explore the top gainers and losers during today's session in our detailed report.
Today's session on Tuesday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.
Curious about the stocks that are showing activity before the opening bell on Tuesday?
Monday's after hours session: top gainers and losers
Sol-Gel Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Requirement ...
Here you can normally see the latest stock twits on SLGL, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: